Company Updates
YPB First Commercial Contract in Mexico
24th August 2016, ASX Announcement Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) has secured its first commercial contract in Mexico through its joint venture (JV) with Affyrmx Group. The initial contract value is US$130,000, with YPB’s proprietary tracer solution to be used to PROTECT redeemable food coupons that are frequently […]
Craig Farrow Joins Bulletproof Board
24th August 2016, ASX Announcement Bulletproof Group Limited (ASX:BPF) welcomes Craig Farrow to the board as a non-executive director, effective today. Mr. Farrow has also accepted the role as chair of the Audit and Risk Committee. Mr. Farrow is a Fellow of Chartered Accountants Australia New Zealand (CAANZ), Australian Institute of Company Directors (AICD) and […]
Proteomics International Expands Diagnostics Portfolio to Endometriosis
24th August 2016, ASX Announcement Life sciences company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) is applying its disruptive proteomics technology platform to new areas of significant unmet medical need. PILL is investigating protein ‘fingerprints’ that can diagnose endometriosis from a simple blood test. Endometriosis affects one in ten women in their reproductive years and […]
Bulletproof Delivers Record Growth: Revenues Up 69%; Full Year Presentation; Full Year Financial Report
24th August 2016, ASX Announcement SYDNEY, Australia – Bulletproof Group Ltd (ASX: BPF) is pleased to announce its results for the 12 months ended 30 June 2016 (FY16) that saw the Company deliver record growth in revenue and solid profit performance. FY16 Results Full year revenues $47.2m, up 69% on FY15, 31% organic growth Underlying […]
Altech Receives Loan Indicative Terms and Conditions
24th August 2016, ASX Announcement Highlights Altech receives lenders first draft indicative term sheet Altech targeting total project debt of US$70 million Export credit cover (ECA) component of US$60 million Sole lender structure proposed for the entire debt portion of up to US$70 million Simplified debt financing and attractive ECA-covered component Altech Chemicals Limited (Altech/the […]
QBiotics Share Offer Update: View Investor Presentation Online; Share Offer Progress; Seven News Story; Frequently Asked Questions Answered
QBIOTICS SHARE OFFER UPDATE The QBiotics Share Offer has now been open for 1 week. Below is an update on how it is progressing, as well as links to further useful information and FAQs about the Offer. UPDATE ON SHARE OFFER PROGRESS The QBiotics Share Offer opened on Monday 15th August and has been very […]
Anti-Cancer Drug Discovered in Rainforest Successfully Tested on Humans
22nd August 2016, The Cairns Post by Daniel Bateman A POTENTIAL cancer cure discovered in Far North Queensland that has been successfully tested on human patients is hoped to become commercially available in four years. Brisbane-based researchers QBiotics have released the results of their first clinical trials of the drug EBC-46. The drug has been […]
Kordia and Thinxtra Internet of Things Network Passes Halfway Mark
Kordia together with partner Thinxtra, says the deployment of a dedicated new Internet of Things (IoT) network, being established nationwide, has officially passed the halfway mark.
Charter Hall Achieves 29% FUM Growth to $17.5 billion; Annual Results Presentation; Full Year Financial Report
22nd August 2016, ASX Announcement Charter Hall Group (ASX:CHC) (Charter Hall or the Group) today announced its full year results for the 12 months to 30 June 2016. Key financial and operational highlights for the period are: Financial highlights: Statutory profit after tax of $215.2 million, up $97.3 million Operating earnings of $124.7 million, up […]
Backed By Leading Investment Groups and Family Offices
